Other Presentations
Switch To Module
  • Poster Presentations
  • Other Presentations
  • Person Lookup
Everything
  • Everything
  • Session Title
  • Session Number
  • Title
  • Presentation Number
  • Author
  • Presenter
Filter By
Day
Presentation Type
Presentation Topic
  • BSTR
  • CASE
  • HF
  • HTX
  • ID
  • LTX
  • MCS
  • NHSAH
  • PEDS
  • PH
  • PHARM
Advanced Search
  • Poster Presentations
  • Other Presentations:
  • Featured
  • Orals
  • Mini Orals

22 - Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis

Oral HTX - Immunosuppression, Therapeutics and Pharmacology

22 - Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis

Presentation Number
22
Presenter
  • J. Duero Posada, Toronto, ON, Canada
Co-Authors
  • M. Alhussein, Toronto, ON, Canada
  • S. Bhagra, Cambridge, United Kingdom
  • A. Dipchand, Toronto, ON, Canada
  • J. Duero Posada, Toronto, ON, Canada
  • S. Fan, Toronto, ON, Canada
  • C. Manlhiot, Toronto, ON, Canada
  • Y. Moayedi, Palo Alto, CA, United States of America
  • H. Ross, Toronto, ON, Canada
  • J. Stehlik, Salt Lake City, UT, United States of America
Previous Poster Next Poster

Previous Eposter

251 - Induction Immunosuppressive Therapy in Cardiac Transplantation: A Systematic Review and Meta-analysis

Next Eposters

491 - Gene Expression Profiling in Murine Orthotopic Lung Transplantation Model of Chronic Lung Allograft Dysfunction (CLAD)
291 - Inhibition of Neutrophil Serine Proteases by Alpha 1 Antitrypsin During Storage Preserves Primary Graft Functions of Transplanted Murine Donor Lungs
442 - Human Leukocyte Compatibility and Heart Transplant Survival Using a Validated Matching Algorithm
314 - The ISHLT 2017 Updated DCD Registry Report
376 - Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation
97 - Extracorporeal Membrane Oxygenation for Cardiogenic Shock: National trends in the United States 2008-2012
412 - Survival and Graft Function in Heart Transplant Patients Receiving Adverse Risk Profile Donor Hearts
454 - NT-proBNP Levels Are Reduced Following Treatment With Growth Hormone in Chronic Heart Failure Due to Ischemic Heart Disease. A Randomized Double Blind Placebo Controlled Trial
31 - Mitochondrial Transplantation Prolongs Cold Preservation Time in Murine Cardiac Transplantation
282 - Frailty Assessment in Lung Transplant Candidates: The Use of the Short Performance Physical Battery

Questions about ePosters? Contact CTI Meeting Technologies Technical Support at ishlt@support.ctimeetingtech.com or 217-398-1792.

Questions about the "ISHLT 38th Annual Meeting and Scientific Sessions"? Contact  communications@ishlt.org.

 CTI Meeting Technologies© All Rights Reserved.